Results 51 to 60 of about 2,458 (176)

Efflux MexAB-Mediated Resistance in P. aeruginosa Isolated from Patients with Healthcare Associated Infections

Pathogens, 2020
Today, one of the most important challenges for physicians is the adequate treatment of infections due to multidrug resistant organism (MDR). Pseudomonas aeruginosa is considered an opportunistic organism causing different types of healthcare associated ...
Rania M. Kishk, Mohamed O. Abdalla, Abdullah A. Hashish, Nader A. Nemr, Nihal El Nahhas, Saad Alkahtani, Mohamed M. Abdel-Daim, Safaa M. Kishk   +7 more
doaj   +1 more source

Potential of Eugenia brejoensis (Mazine) Essential Oil in Combating Multidrug‐Resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa

Chemistry &Biodiversity, Volume 23, Issue 1, January 2026.
ABSTRACT The genus Eugenia has a long history of use in traditional medicine for treating various conditions, including infectious diseases, gastrointestinal disorders, and skin problems. Essential oils derived from Eugenia species are known for their medicinal properties and have been studied for their antimicrobial and bioactive potential. This study
Jonathan Mandú de Araújo, Amanda Vieira de Barros, Fábio Henrique Galdino Dos Santos, Weslley Felix De Oliveira, Daniela Maria do Amaral Ferraz Navarro, Márcia Vanusa da Silva, Bruno Oliveira de Veras, John Eversong Lucena de Vasconcelos, Henrique Douglas Melo Coutinho, Maria Betânia de Melo Oliveira, Maria Tereza dos Santos Correia   +10 more
wiley   +1 more source

Outbreak of extensively drug-resistant Acinetobacter baumannii indigo-pigmented strains [PDF]

, 2013
Acinetobacter baumannii pigmented strains are not common in clinical settings. In the present work we report an outbreak caused by indigo-pigmented A. baumannii strains isolated in an acute hospital in Argentina from March to September 2012.
Almuzara, Marisa, Bakai, Romina, Centron, Daniela, Gulone, Lucia, Pallone, Elida, Ramirez, Maria Soledad, Rodriguez, Rocio, Vilacoba, Elisabet   +7 more
core   +1 more source

An Investigation of Colistin Heteroresistance in Klebsiella pneumoniae Isolates in Iran

BioMed Research International, Volume 2026, Issue 1, 2026.
Background According to the World Health Organization 2024 bacterial priority pathogens list, carbapenem‐resistant Enterobacterales (CRE) were listed among the critical priority pathogens. Heteroresistance (i.e., a bacterial isolate that appears susceptible but harbors resistant subpopulations) represents a challenge in traditional laboratory testing ...
Zohreh Riahi Rad, Zahra Riahi Rad, Hossein Goudarzi, Mehdi Goudarzi, Mohsen Javidi, Javad Yasbolaghi Sharahi, Masoud Kargar, Ali Hashemi, Baisakhi Banerjee   +8 more
wiley   +1 more source

Risk factors for colistin-resistant, extensively drug-resistant (XDR) and pandrug-resistant (PDR) Acinetobacter baumannii infections: a review

Expert Review of Anti-infective Therapy
Acinetobacter baumannii clinical isolates commonly have high antimicrobial resistance levels. We evaluated the risk factors associated with colistin-resistant, extensively drug-resistant (XDR), and pan-drug-resistant (PDR) Acinetobacter baumannii. A literature review was done using three electronic resources, encompassing 18 observational studies with ...
Vrysis, Christos, Kontogiannis, Dimitrios S., Ntourakis, Dimitrios, Kakoullis, Stylianos A., Falagas, Matthew E.   +4 more
openaire   +1 more source

Polymyxin b therapy for multidrug resistant gram negative infections : outcome and risk factors for treatment failure in critical care [PDF]

, 2015
Objective: Polymyxins have re-administered in clinical practice due to the dry antibiotic development pipeline and worldwide increasing infections caused by multi-drug resistant (MDR) gram negative bacteria.
Ismail, Bahiah
core  

A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa [PDF]

, 2011
Background Colistin is used as last treatment option for pneumonia associated with multidrug-resistant (MDR) Pseudomonas spp.. Literature about the best administration mode (inhalation versus parenteral treatment) is lacking.
Reinout Naesens, Erika Vlieghe, Walter Verbrugghe, Philippe Jorens, Margareta Ieven   +4 more
core   +2 more sources

Clinical Epidemiological Analysis of the Genotypic Spectrum and Mortality Risk in Carbapenem‐Resistant Klebsiella pneumoniae (CRKP) Infections

Canadian Journal of Infectious Diseases and Medical Microbiology, Volume 2026, Issue 1, 2026.
Background Carbapenem‐resistant Klebsiella pneumoniae (CRKP) has become a global public health threat, with significantly increased morbidity and mortality among high‐risk inpatients. High‐risk genotypes of CRKP, primarily including K. pneumoniae carbapenemase (KPC), oxacillinase‐48–like (OXA‐48–like), New Delhi metallo‐β‐lactamase (NDM), imipenemase ...
Qiongfang Zhang, Ze Fang, Bo Fang, Hailing Zeng, Jiaojiao Xu, Muhammad Abu Bakr Shabbir   +5 more
wiley   +1 more source

Resistência aos antibióticos: uma ameaça crescente a nível europeu [PDF]

, 2012
Durante a última década tem-se verificado um aumento das taxas de resistência antimicrobiana dos principais agentes patogénicos, sobretudo em bactérias de gram negativo (K. pneumoniae, E. coli e P. aeruginosa).
Freitas, Francisco, Machado, José
core  

Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis [PDF]

, 2014
Background Increasing rates of resistant and multidrug-resistant (MDR) P. aeruginosa in hospitalized patients constitute a major public health threat.
Gavaghan, M., Menon, V., Nathwani, D., Raman, G., Sulham, K.   +4 more
core   +3 more sources